Keyphrases
Older People
100%
Meta-analysis
100%
Systematic Meta-analysis
100%
Renin-angiotensin System Inhibitors
100%
Physical Performance
100%
Standardized Mean Difference
80%
Angiotensin Receptor Blockers
80%
I(2)
60%
Angiotensin-converting Enzyme Inhibitor (ACEi)
60%
Randomized Controlled Trial
40%
Usual Care
20%
Observational Data
20%
Muscle Function
20%
Treatment Duration
20%
Skeletal muscle
20%
Heart Failure
20%
Placebo
20%
Random Effects Model
20%
Functional Impairment
20%
Publication Bias
20%
Antihypertensive Drugs
20%
Treatment Effect
20%
ACE Inhibitors
20%
RevMan
20%
Inhibitor-2
20%
Sarcopenia
20%
Short Physical Performance Battery
20%
Risk of Bias
20%
Multiple Interventions
20%
Preclinical Data
20%
Low-to-moderate
20%
Healthy Older People
20%
Funnel Plot
20%
Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
100%
Angiotensin
100%
Physical Performance
100%
ACE Inhibitor
80%
Angiotensin Receptor Antagonist
80%
Randomized Controlled Trial
40%
Disease
20%
Placebo
20%
Muscle Function
20%
Functional Disease
20%
Treatment Effect
20%
Treatment Duration
20%
Random Effects Model
20%
Antihypertensive Agent
20%
Congestive Heart Failure
20%
Sarcopenia
20%
Funnel Plot
20%
Skeletal Muscle
20%
Nursing and Health Professions
Systematic Review
100%
Meta Analysis
100%
Dipeptidyl Carboxypeptidase Inhibitor
100%
Angiotensin
100%
Angiotensin Receptor Antagonist
100%
Disease
25%
Antihypertensive Agent
25%
Functional Disease
25%
Placebo
25%
Treatment Duration
25%
Congestive Heart Failure
25%
Sarcopenia
25%
Neuroscience
Meta-Analysis
100%
Angiotensin
100%
ACE Inhibitor
100%
Angiotensin Receptor
100%
Randomized Controlled Trial
50%
Skeletal Muscle
25%
Placebo
25%
Antihypertensive Agent
25%
Psychology
Systematic Review
100%
Meta-Analysis
100%
Standardized Mean Difference
100%
Random Effects Model
25%
Functional Impairment
25%
Publication Bias
25%